Eltromag 25 Tablet (Eltrombopag 25 mg)

Eltromag 25 is a prescription medicine containing eltrombopag 25 mg. The product shown is manufactured by Cipla and is supplied as an oral tablet. Eltrombopag belongs to a group of medicines called thrombopoietin receptor agonists. It is used under medical supervision for selected blood disorders associated with low platelet counts and certain forms of aplastic anemia.

Because eltrombopag can affect platelet levels and liver function, treatment generally requires regular medical follow-up and laboratory monitoring. It should be used only when prescribed by a qualified healthcare professional.

What is Eltromag 25?

Eltromag 25 contains eltrombopag, an active medicine that helps stimulate the body’s production of platelets. Platelets are blood cells that play an important role in normal blood clotting.

Eltrombopag works by acting on the thrombopoietin receptor, a receptor involved in the production of blood cells in the bone marrow. By stimulating this pathway, eltrombopag can increase platelet production in appropriate patients.

Doctors may prescribe eltrombopag for particular conditions involving thrombocytopenia, or a low platelet count, and for certain patients with aplastic anemia. The exact indication depends on the patient’s condition, age, treatment history, and applicable prescribing guidelines.

Eltromag 25 should not be started, stopped, or adjusted without medical advice.

Eltromag 25 Uses

Depending on the clinical situation, eltrombopag may be prescribed for:

• Management of certain forms of immune thrombocytopenia (ITP).
• Management of thrombocytopenia associated with specific underlying conditions.
• Treatment of selected patients with aplastic anemia.
• Supporting platelet production when a healthcare professional determines that stimulation of platelet production is appropriate.

The medicine is intended to help achieve an appropriate platelet level rather than simply produce the highest possible platelet count. Excessively high platelet levels can also create health risks, so monitoring is important.

This medicine should only be taken under the supervision of a qualified healthcare professional.

Eltromag 25 Benefits

When appropriately prescribed, Eltromag 25 may provide benefits such as:

• Supporting the production of platelets in the bone marrow.
• Helping manage low platelet counts in selected blood disorders.
• Helping reduce the risk associated with very low platelet levels in appropriate patients.
• Supporting ongoing management of certain chronic blood conditions.
• Providing a treatment option when a thrombopoietin receptor agonist is considered suitable.

Eltrombopag does not cure every underlying condition that causes low platelets. Its benefits depend on the patient’s diagnosis and response to treatment.

How Does Eltromag 25 Work?

Eltrombopag is a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin receptor on blood-forming cells in the bone marrow.

This stimulates signaling pathways involved in the development of megakaryocytes, the cells responsible for producing platelets. As a result, platelet production can increase in patients who respond to the medicine.

The response differs between individuals, which is why doctors monitor blood counts during treatment and adjust treatment when necessary.

How to Take Eltromag 25

Eltromag 25 should be taken exactly as prescribed by the treating healthcare professional.

Important administration considerations include:

• Take the medicine according to the prescription.
• Swallow the tablet whole; tablets should not be crushed, chewed, or split unless specifically directed by a healthcare professional.
• Eltrombopag is generally taken on an empty stomach.
• Calcium-rich foods and products containing minerals such as calcium, iron, magnesium, aluminum, zinc, or selenium can affect eltrombopag absorption. Appropriate separation from these products is important.
• Antacids containing calcium, aluminum, or magnesium may also interact with eltrombopag.
• Do not change the prescribed amount or treatment schedule on your own.
• If a dose is missed, follow the instructions provided by your doctor or pharmacist rather than taking an extra dose.

The appropriate dose varies according to the medical condition, age, laboratory results, ethnicity in some treatment settings, liver function, and response to therapy.

Eltromag 25 Side Effects

Like all medicines, Eltromag 25 may cause side effects, although not everyone experiences them.

Common Side Effects

Possible side effects of eltrombopag include:

• Headache
• Cough
• Fever
• Tiredness or fatigue
• Nausea or digestive symptoms in some patients

The severity and frequency of side effects can vary between individuals.

Serious Side Effects

Eltrombopag can cause potentially serious problems, including liver injury and blood clots. Seek prompt medical attention for symptoms such as:

• Yellowing of the skin or eyes
• Dark urine
• Significant or unusual tiredness
• Pain in the upper-right area of the abdomen
• Unusual abdominal swelling or confusion
• Swelling, warmth, redness, or pain in a leg
• Sudden breathing difficulty or chest pain
• Sudden weakness, numbness, speech difficulties, or vision changes

Eltrombopag can also be associated with changes in platelet levels and requires appropriate monitoring.

If side effects persist or become severe, contact your healthcare provider promptly.

Warnings and Precautions

Before treatment, tell your doctor if you have:

• Liver disease or a history of liver problems.
• A history of blood clots or conditions that increase clotting risk.
• A history of cataracts or vision problems.
• Other blood disorders.
• A history of spleen removal.
• Any known allergy to eltrombopag or its ingredients.

Liver function and blood counts may need to be checked regularly during treatment. In some patients, eye examinations may also be recommended.

Pregnancy and Breastfeeding

Tell your healthcare professional if you are pregnant, planning pregnancy, or breastfeeding. The decision to use eltrombopag during pregnancy requires medical assessment of potential benefits and risks. MedlinePlus advises patients receiving eltrombopag not to breastfeed during treatment.

Liver Disease

Eltrombopag may affect liver function and requires particular caution in patients with liver disease. Signs of liver problems should be reported promptly.

Alcohol

Because eltrombopag can affect the liver, discuss alcohol consumption with your healthcare professional, particularly if you have existing liver problems.

Driving

If you experience symptoms such as dizziness, visual changes, or significant tiredness, speak with your healthcare professional before driving or operating machinery.

Drug Interactions

Eltrombopag can interact with other medicines, supplements, and mineral-containing products.

Tell your doctor or pharmacist about all medicines you use, including:

• Prescription medicines
• Over-the-counter medicines
• Antacids
• Vitamins and mineral supplements
• Iron or calcium products
• Herbal or nutritional supplements

Calcium, iron, magnesium, aluminum, zinc, and selenium-containing products can reduce eltrombopag absorption when taken too close to the medicine. Your healthcare professional can advise you about appropriate timing.

Storage Instructions

Store Eltromag 25 according to the storage conditions stated on its packaging and pharmacy instructions.

General precautions include:

• Keep the tablets in their original container.
• Protect the medicine from excessive heat and moisture.
• Keep it out of the reach of children.
• Do not use the medicine after its expiry date.
• Dispose of unused medicine appropriately according to local pharmacy or healthcare guidance.

Eltromag 25 Manufacturer

The package shown identifies Cipla as the manufacturer. Product packaging, formulation details, and regulatory information can vary by market, so the information printed on the supplied pack should be checked before use.

Frequently Asked Questions

1. What is Eltromag 25 used for?

Eltromag 25 contains eltrombopag, a thrombopoietin receptor agonist. It may be prescribed for selected conditions associated with low platelet counts and for certain forms of aplastic anemia. The appropriate indication depends on the patient’s diagnosis and treatment plan.

2. How does Eltromag 25 work?

Eltrombopag stimulates the thrombopoietin receptor involved in blood-cell production in the bone marrow. This can encourage the production of megakaryocytes and increase platelet production in patients who respond to treatment.

3. Is Eltromag 25 safe?

Eltrombopag can be appropriate for selected patients when prescribed and monitored by a healthcare professional. However, it has important risks, including liver toxicity and blood-clotting complications. Regular blood tests and other monitoring may therefore be required.

4. Can Eltromag 25 be taken long term?

Some patients may receive eltrombopag as part of longer-term treatment, depending on their condition and response. Long-term use requires medical monitoring because platelet levels, liver function, and other factors may change during treatment.

5. What happens if I miss a dose?

Do not take an extra dose to compensate for a missed dose unless your healthcare professional specifically tells you to do so. Follow the missed-dose instructions supplied with your prescription or contact your pharmacist or doctor for individualized guidance.

6. Can I stop taking Eltromag 25 suddenly?

Do not stop eltrombopag without medical advice. Platelet counts can fall again after treatment is discontinued, potentially increasing the risk of bleeding in some patients. Continued monitoring after stopping treatment may therefore be necessary.

7. Can Eltromag 25 be taken with food?

Eltrombopag tablets are generally taken on an empty stomach. Foods and products containing substantial amounts of calcium can interfere with absorption, so the timing of meals and mineral-containing products is important. Follow the administration instructions provided by your healthcare professional.

8. What are the common Eltromag 25 side effects?

Reported side effects can include headache, cough, fever, and tiredness. Other reactions may occur. Serious symptoms involving the liver, blood clots, breathing, chest pain, neurological changes, or vision should receive prompt medical attention.

9. Who should avoid or use Eltromag 25 with caution?

People with liver disease, previous blood clots, clotting risk factors, certain blood disorders, or other significant medical conditions should discuss these issues with their healthcare professional before treatment. Any allergy to eltrombopag or its ingredients should also be reported.

10. How should Eltromag 25 be stored?

Keep Eltromag 25 in its original container, protected from excessive heat and moisture and away from children. Follow the storage instructions printed on the product packaging and provided by the pharmacist.

Medical Disclaimer

This information about Eltromag 25 (eltrombopag 25 mg) is provided for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Do not self-medicate or change your treatment based solely on information on a website. Always follow the prescription and instructions provided by your qualified healthcare professional. Individual responses to eltrombopag can vary, and treatment may require regular blood tests and medical monitoring.